3CC | Third Culture Capital
Venture capitalBoston Β· Pre-SeedβSeries A Β· 6 people tracked
Investment thesis
3CC invests at the confluence of healthcare, technology, and access. The firm backs builders who have experienced being an outsider and have transformed that perspective into an edge. Its focus centers on healthcare innovation, combining technology and improved access to care.
Source: firm website, verified Aug 3, 2026.
Team Β· 6 people
from the firm's website & public directories
What they invest in
from 12 of 17 portfolio companiesHealthtech Γ10Digital Health Γ7AI & Machine Learning Γ4FemTech Γ3Biotech Γ2Enterprise Software Γ2Medical Devices Γ2SaaS Γ2
HQs:United StatesΓ5FranceΓ1IsraelΓ1VietnamΓ1
Investments Β· 17 tracked
founders shown can be your intro pathAcoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection.
BiotechDeep TechMedical Devices
Daniele Foresti(Founder)
Ciba Health provides an AI-powered virtual chronic care platform designed to manage Type 2 diabetes, obesity, and other chronic conditions for employers, health plans, and health systems.
AI & Machine LearningDigital HealthHealthtech
Innocent Clement(Executive Officer, Director)
BoardMiraj Sanghvi(Director)Peter Lee(Director)
Docosan is a healthcare booking platform that lets families in Vietnam find and schedule appointments with hospitals, clinics, doctors, and testing centers, including in-person, at-home, and online consultations.
Digital HealthHealthtechMarketplaces
IntusCare provides a technology platform for PACE (Programs of All-Inclusive Care for the Elderly) organizations, including tools like CareHub for operations and compliance, PRISM for population health and utilization management, and IRIS for risk adjustment.
Digital HealthHealthtechSaaS
Helm Health provides benefit design and member engagement tools for health plans, incorporating cost and quality data into coverage decisions, bundling claims into transparent pricing, and offering provider search functionality.
Enterprise SoftwareHealthtechInsurTechSan Francisco, US
Lime is a patient experience platform that automates the collection and analysis of patient-reported experience measures (PREMs) and patient-reported outcome measures (PROMs).
Digital HealthHealthtechSaaS
Mahmee provides wraparound maternal and infant healthcare support through a team of nurses, doulas, lactation consultants, and mental health specialists, serving pregnant and postpartum families in the United States.
Digital HealthFemTechHealthtechCalifornia, US
Melissa Hanna(Founder)Linda Hanna(Co-Founder & Director of Care)
ViTAA offers the AiORTA Suite, a cloud-based platform that uses explainable AI to analyze CT scans and map the strength and weakness of aortic aneurysm tissue.
AI & Machine LearningHealthtechMedical Devices
Randy Moore(Co-founder)
Zuri is a digital fertility clinic offering at-home testing for both partners, medical concierge services, and app-based support to help couples manage the fertility treatment process.
Digital HealthFemTechHealthtechChicago, US
Giuliana Zaccardelli(Executive Officer, Director)Blair Matthews(Director)
Frequently asked questions
- What stage does 3CC | Third Culture Capital invest at?
- 3CC | Third Culture Capital invests at the Pre-Seed, Seed, Series A stages.
- What is 3CC | Third Culture Capital's typical check size?
- 3CC | Third Culture Capital typically writes checks of $250K β $1M.
- What sectors does 3CC | Third Culture Capital focus on?
- 3CC | Third Culture Capital focuses on Biotech, Digital Health, Healthtech.
- Where is 3CC | Third Culture Capital located?
- 3CC | Third Culture Capital is headquartered in Boston, US.
- Does 3CC | Third Culture Capital lead rounds?
- Yes, 3CC | Third Culture Capital leads investment rounds.
Images
Similar investors
Lux Capital's portfolio page showcasing select companies across science and technology sectors including AI infrastructure, aerospace, biotech, and productivity software.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Cancer Focus Fund is an oncology-focused investment fund established in partnership with The University of Texas MD Anderson Cancer Center to fund and support promising cancer therapies.
Debiopharm Innovation Fund is the strategic corporate venture fund of Debiopharm, investing in and advising health tech startups that are transforming pharmaceutical R&D and cancer care.